John V. Balen is Director at Cardlytics, Inc. (CDLX). They have made 11 open-market trades across 2 companies since 2011, most recently 2023-05-24.
CIK 0001181211
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $996K since 2020, against 3 sales. Across 8 scored buys the stock is down 10.7% at ninety days, and 15.8 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 38% | 25% |
| Avg Move | +0.0% | -1.2% | -10.7% |
| Alpha | +0.2% | -0.5% | -15.8% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDLX | BUY | 2022-11-07 | 2022-11-09 | $4.04 | $61K | +1.5% | +23.6% | +79.8% |
| CDLX | BUY | 2022-08-12 | 2022-08-15 | $16.79 | $84K | -11.2% | -27.6% | -70.4% |
| CDLX | BUY | 2022-05-27 | 2022-05-31 | $27.40 | $137K | -5.7% | -17.1% | -49.0% |
| CDLX | BUY | 2022-05-09 | 2022-05-10 | $29.18 | $88K | -1.0% | -6.8% | -44.6% |
| CDLX | BUY | 2021-08-30 | 2021-08-31 | $89.85 | $90K | +1.0% | -8.7% | -24.5% |
| CDLX | BUY | 2021-08-19 | 2021-08-23 | $80.01 | $160K | +15.7% | +11.2% | -17.8% |
| CDLX | BUY | 2021-05-14 | 2021-06-01 | $95.87 | $288K | +3.7% | +18.4% | -16.3% |
| CDLX | BUY | 2020-03-12 | 2020-03-16 | $44.83 | $90K | -3.8% | -3.0% | +56.8% |
| CDLX | SELL | 2019-08-12 | 2019-08-14 | $31.93 | $6.0M | +1.6% | +4.6% | +17.4% |
| ACTV | SELL | 2012-03-02 | 2012-03-06 | $16.00 | $3.1M | N/A | N/A | N/A |
| ACTV | SELL | 2011-05-31 | 2011-06-02 | $15.00 | $20.6M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.